durapatite has been researched along with Adenocarcinoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JC; Fang, HW; Lin, FH; Tang, TP; Tseng, CL; Wu, YC | 1 |
| Abe, T; Ikoma, T; Kobayashi, M; Nakamura, S; Ochiai, N; Sakane, M | 1 |
| Cox, RF; Harmey, JH; Hernandez-Santana, A; McMahon, G; Morgan, MP; Ramdass, S | 1 |
| Cooke, MM; McCarthy, GM; Morgan, MP; Sallis, JD | 1 |
| Kamei, Y; Kanno, T; Nakajima, T; Nakanishi, Y; Sano, H; Yoshimura, Y | 1 |
| Daumas, M; Fanjul, M; Hollande, E; Levrat di Donato, JH; Palevody, C; Puech, J; Ratovo, G | 1 |
| Cavanaugh, PG; Nicolson, GL | 1 |
7 other study(ies) available for durapatite and Adenocarcinoma
| Article | Year |
|---|---|
Development of lattice-inserted 5-Fluorouracil-hydroxyapatite nanoparticles as a chemotherapeutic delivery system.
Topics: 3T3 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Drug Carriers; Durapatite; Fluorouracil; Humans; Lung Neoplasms; Mice; Nanoparticles | 2015 |
Intraosseous delivery of paclitaxel-loaded hydroxyapatitealginate composite beads delaying paralysis caused by metastatic spine cancer in rats.
Topics: Adenocarcinoma; Alginates; Animals; Antineoplastic Agents, Phytogenic; Drug Carriers; Durapatite; Female; Glucuronic Acid; Hexuronic Acids; Microspheres; Paclitaxel; Paralysis; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Spinal Neoplasms | 2008 |
Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisation.
Topics: Adenocarcinoma; Alkaline Phosphatase; Animals; Breast Neoplasms; Calcinosis; Calcium Carbonate; Calcium Oxalate; Cell Line, Tumor; Cell Transformation, Neoplastic; Durapatite; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Phosphates | 2012 |
Phosphocitrate inhibits calcium hydroxyapatite induced mitogenesis and upregulation of matrix metalloproteinase-1, interleukin-1beta and cyclooxygenase-2 mRNA in human breast cancer cell lines.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Breast Neoplasms; Calcinosis; Cell Division; Citrates; Cyclooxygenase 2; Dinoprostone; Durapatite; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1; Isoenzymes; Macrolides; Matrix Metalloproteinase 1; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation | 2003 |
Anterior cranial base reconstruction using a hydroxyapatite-tricalciumphosphate composite (Ceratite) as a bone substitute.
Topics: Adenocarcinoma; Aged; Bone Substitutes; Brain Neoplasms; Calcium Phosphates; Durapatite; Humans; Hydroxyapatites; Male; Paranasal Sinus Neoplasms; Skull | 1995 |
Calcium phosphate deposits in domes of human pancreatic adenocarcinoma (Capan-1) cell cultures.
Topics: Adenocarcinoma; Alkaline Phosphatase; Biological Transport, Active; Calcium Phosphates; Calcium-Transporting ATPases; Cell Division; Crystallization; Durapatite; Humans; Hydroxyapatites; Liver Neoplasms; Membrane Proteins; Neoplasm Proteins; Pancreatic Neoplasms; Tumor Cells, Cultured | 1990 |
Purification and some properties of a lung-derived growth factor that differentially stimulates the growth of tumor cells metastatic to the lung.
Topics: Adenocarcinoma; Animals; Cell Division; Cell Line; Chromatography; Chromatography, Gel; Chromatography, Ion Exchange; Culture Media; Durapatite; Electrophoresis, Polyacrylamide Gel; Growth Substances; Hydroxyapatites; Kinetics; Lung; Lung Neoplasms; Mammary Neoplasms, Experimental; Molecular Weight; Rats | 1989 |